Ingredion trades at $113.54 per share and has stayed right on track with the overall market, losing 6.7% over the last six months while the S&P 500 is down 2.1%. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

Is there a buying opportunity in Ingredion, or does it present a risk to your portfolio? See what our analysts have to say in our full research report, it’s free.

Why Is Ingredion Not Exciting?

Despite the more favorable entry price, we're sitting this one out for now. Here are three reasons there are better opportunities than INGR and a stock we'd rather own.

1. Revenue Spiraling Downwards

A company’s long-term sales performance can indicate its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Over the last three years, Ingredion’s demand was weak and its revenue declined by 3.1% per year. This wasn’t a great result and is a sign of lacking business quality.

2. Projected Revenue Growth Is Slim

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite.

Over the next 12 months, sell-side analysts expect Ingredion’s revenue to rise by 2%. Although this projection implies its newer products will catalyze better top-line performance, it is still below average for the sector.

3. Free Cash Flow Margin Dropping

Free cash flow isn't a prominently featured metric in company financials and earnings releases, but we think it's telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.

As you can see below, Ingredion’s margin dropped by 8.3 percentage points over the last year. If its declines continue, it could signal increasing investment needs and capital intensity. Ingredion’s free cash flow margin for the trailing 12 months was 7.1%.

Final Judgment

Ingredion isn’t a terrible business, but it doesn’t pass our quality test. After the recent drawdown, the stock trades at 10.1× forward P/E (or $113.54 per share). This valuation is reasonable, but the company’s shakier fundamentals present too much downside risk. We're pretty confident there are superior stocks to buy right now. Let us point you toward one of Charlie Munger’s all-time favorite businesses.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.